Press release
Investigation announced for Investors who lost money with shares of DermTech, Inc. (NASDAQ: DMTK)
An investigation for investors in DermTech, Inc. (NASDAQ: DMTK) shares over potential securities laws violations by DermTech, Inc.
Investors who purchased shares of DermTech, Inc. (NASDAQ: DMTK), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of DermTech, Inc. (NASDAQ: DMTK) concerning whether a series of statements by DermTech, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
San Diego, CA based DermTech, Inc., a molecular diagnostic company, develops and markets novel non-invasive genomics tests to aid in the diagnosis and management of various skin conditions, including skin cancer and inflammatory diseases in the United States. DermTech, Inc. reported that its annual Total Revenue rose from $11.83 million in 2021 to $14.51 million in 2022, and that its Net Loss increased from $78.33 million in 2021 to $116.68 million in 2022.
Shares of DermTech, Inc. (NASDAQ: DMTK) declined from over $84 per share in February 2021 to as low as $1.55 per share in late December 2022.
On April 11, 2023, NASDAQ: DMTK shares closed at $3.68 per share.
Those who purchased shares of DermTech, Inc. (NASDAQ: DMTK) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors who lost money with shares of DermTech, Inc. (NASDAQ: DMTK) here
News-ID: 3008716 • Views: …
More Releases from Shareholders Foundation
Lawsuit Alert: Investors who lost money with shares of Revance Therapeutics, Inc …
An investor, who purchased shares of Revance Therapeutics, Inc. (NASDAQ: RVNC), filed a lawsuit over alleged violations of Federal Securities Laws by Revance Therapeutics, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased a significant amount of shares of Revance Therapeutics, Inc. (NASDAQ: RVNC) between February 29, 2024 and December 6, 2024, and / or those who purchased anyNASDAQ: RVNC shares prior to February 2024 and continue…
Lawsuit filed for Investors who lost money with shares of AstraZeneca PLC (NASDA …
An investor, who purchased shares of AstraZeneca PLC (NASDAQ: AZN), filed a lawsuit in the U.S. over alleged violations of Federal Securities Laws by AstraZeneca PLC in connection with certain allegedly false and misleading statements made between February 23, 2022 and December 17, 2024.
Investors who purchased a significant amount of shares of AstraZeneca PLC (NASDAQ: AZN) between February 23, 2022 and December 17, 2024, have certain options and for certain…
Lawsuit filed for Investors who lost money with shares of Applied Therapeutics, …
An investor, who purchased shares of Applied Therapeutics, Inc. (NASDAQ: APLT), filed a lawsuit over alleged violations of Federal Securities Laws by Applied Therapeutics, Inc.
Investors who purchased shares of Applied Therapeutics, Inc. (NASDAQ: APLT) have certain options and for certain investors are short and strict deadlines running. Deadline: February 18, 2025. NASDAQ: APLT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
New York based Applied…
Investigation announced for Long-Term Investors in shares of WEBTOON Entertainme …
An investigation on behalf of current long-term investors in shares of WEBTOON Entertainment Inc. (NASDAQ: WBTN) concerning potential breaches of fiduciary duties by certain directors of WEBTOON Entertainment Inc. was announced.
Investors who are current long term investors in WEBTOON Entertainment Inc. (NASDAQ: WBTN) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long…
More Releases for DermTech
Cancer Cell Biopsy Service Market Size 2022 | Opportunities By Industry Share, S …
The Cancer Cell Biopsy Service reportâs qualitative and quantitative data focuses on drivers, regional growth, opportunities, influencing trends, and challenges. The report also utilizes various analyzing tools like value chain analysis, supply chain analysis, SWOT analysis, and more. Furthermore, the research study provides cautious information about the significant perspective like affiliation, acquisitions, latest affiliation and various aspects that impacts the global Cancer Cell Biopsy Service market development.
The key regions covered…
North America Skin Cancer Diagnostics Market is Rapidly Growing with Huge Applic …
According to a new market research report "North America Skin Cancer Diagnostics Market" by Component Application, Deployment Mode, Vertical, and Region forecast to 2028 published by Business Market Insights, The North America skin cancer diagnostics market is expected to reach US$ 2,354.2 million by 2028 from US$ 1,423.0 million in 2021; it is estimated to grow at a CAGR of 7.5% from 2021 to 2028.
Breast, lung, colon, prostate, skin, and…
Teledermatology Market to Reach $44.86 Billion by 2027; Presence of Several Larg …
The global "Teledermatology Market" is projected to reach USD 44.86 billion by the end of 2027. The presence of several large scale companies in this sector will have a huge impact on the growth of the overall market in the coming years. According to a report published by Fortune Business Insights, titled "Teledermatology Market Size, Share & COVID-19 Impact Analysis, By Type (Products & Services), By Modality (Store-and-forward (Asynchronous), Real-time…
Global Teledermatology Market | Expected to Reach USD 44.86 billion (at CAGR of …
The global “Teledermatology Market” is projected to reach USD 44.86 billion by the end of 2027. The presence of several large scale companies in this sector will have a huge impact on the growth of the overall market in the coming years. According to a report published by Fortune Business Insights, titled “Teledermatology Market Size, Share & COVID-19 Impact Analysis, By Type (Products & Services), By Modality (Store-and-forward (Asynchronous), Real-time…
Pigmented Lesion Treatment Market is Expected to Expand at an Impressive Rate by …
Pigmented Lesion are skin lesions that are brown, black or blue in color due to melanin or blood or exogenous pigment like tattoos. It is referred to as melanocytic proliferations which under microscope appears abnormal and may be a symptom of skin cancer.
The Pigmented Lesion Treatment market is anticipated to grow in the forecast, owing to the factors such as rising prevalence of pigmented lesions, growing population of ageing people,…
Melanoma Detection Market Size, Share, Development by 2025
Market Research Report Store offers a latest published report on Melanoma Detection Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report.
This report focuses on the key global Melanoma Detection players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Melanoma Detection with respect to individual growth…
